Chris was born and raised in Bavaria, Germany, and received a Diploma in Chemistry from the University of Wuerzburg. In 2011, he earned a PhD from ETH Zurich under supervision of Prof. Erick Carreira after completing a natural product total synthesis. Chris then moved to Boston, MA, for postdoctoral studies in microbiology and chemical biology with Prof. Dan Kahne at Harvard University, and then joined the Global Discovery Chemistry Group at Novartis in Cambridge, MA, in 2013. While at Novartis, Chris worked and published on chemical modification of mRNA for gene therapy, cyclic peptides, and various small molecule drug discovery projects. His interest in immunomodulatory molecules led Chris to join the Discovery Chemistry group at Genentech in South San Francisco, CA, in 2020, where he is currently a project team leader and works in close liaison with the Immunology department on early research efforts. Chris also enjoys the outdoors with his family and friends, skiing, surfing, and talking about watches.